Technology Transfer Office
Actualité - Innovation

Spotlight Medical Emerges from Stealth to Tackle the Critical Issue of Inadequate Cancer Treatments

Spotlight Medical, new spin-off of Institut Curie, proudly announced its official launch. This innovative start-up aims to transform cancer treatment using advanced artificial intelligence (AI), leveraging a unique technology developed by researchers and clinicians from Institut Curie, Mines Paris – PSL, and Inserm, over several years.

Founded by a physician, an AI researcher, and an entrepreneur, Spotlight Medical addresses the critical issue of inadequate cancer treatments. Many patients face over- or undertreatment, leading to reduced survival rates and unnecessary side effects. The founders believe that patient data holds untapped potential, which AI can harness to significantly improve patient care by identifying the most appropriate treatment for each individual.

Our incredibly powerful and innovative technology has unlocked unprecedented capabilities in tailoring cancer treatments.The potential impact on patient survival rates and quality of life is immense, heralding a new era in personalized cancer treatment. Our mission is to make it a reality for patients and their families.

said Sylvain Berlemont, co-founder and CEO of Spotlight Medical.

Spotlight Medical’s clinical AI tests extract meaningful biological information from patient data within a secure and regulated framework. This data predicts treatment response efficacy, guiding oncologists in selecting the most suitable options for their patients. The technology is versatile, capable of handling various cancer types, with the first test focusing on a specific use case to be announced soon.

The strategic alliance between Institut Curie and Spotlight Medical combines clinical expertise, extensive clinical data, advanced technology, and industrial resources to accelerate the development and implementation of innovative cancer solutions.

The launch of Spotlight Medical, based on the pioneer work conducted in Institut Curie’s lab and leveraged by Institut Curie’s clinical data, is further proof of our ability to develop high-potential entrepreneurial projects. Spotlight Medical is paving the way for a major, innovative, and promising improvement of patient treatments. 

said Dr. Cécile Campagne, Director of Institut Curie’s Technology Transfer Office.


Download the press release